We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Study Shows Favorable Results for Celebrex, Mostly Bad News for Vioxx
Canadian Study Shows Favorable Results for Celebrex, Mostly Bad News for Vioxx
February 2, 2005
Pfizer’s painkiller Celebrex received a vote of confidence this week in the form of a new Canadian study that showed the drug posed no increased risk of a first heart attack in elderly patients.